IBDEI08M ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11391,1,4,0)
 ;;=4^854.11
 ;;^UTILITY(U,$J,358.3,11391,2)
 ;;=^274721
 ;;^UTILITY(U,$J,358.3,11392,0)
 ;;=854.12^^55^619^113
 ;;^UTILITY(U,$J,358.3,11392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11392,1,3,0)
 ;;=3^TBI-Closed Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,11392,1,4,0)
 ;;=4^854.12
 ;;^UTILITY(U,$J,358.3,11392,2)
 ;;=^274722
 ;;^UTILITY(U,$J,358.3,11393,0)
 ;;=854.13^^55^619^115
 ;;^UTILITY(U,$J,358.3,11393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11393,1,3,0)
 ;;=3^TBI-Closed,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,11393,1,4,0)
 ;;=4^854.13
 ;;^UTILITY(U,$J,358.3,11393,2)
 ;;=^274723
 ;;^UTILITY(U,$J,358.3,11394,0)
 ;;=854.14^^55^619^116
 ;;^UTILITY(U,$J,358.3,11394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11394,1,3,0)
 ;;=3^TBI-Closed,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,11394,1,4,0)
 ;;=4^854.14
 ;;^UTILITY(U,$J,358.3,11394,2)
 ;;=^274724
 ;;^UTILITY(U,$J,358.3,11395,0)
 ;;=908.3^^55^619^17
 ;;^UTILITY(U,$J,358.3,11395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11395,1,3,0)
 ;;=3^Carotid Cavernous Fistula,Late Effect
 ;;^UTILITY(U,$J,358.3,11395,1,4,0)
 ;;=4^908.3
 ;;^UTILITY(U,$J,358.3,11395,2)
 ;;=^275249
 ;;^UTILITY(U,$J,358.3,11396,0)
 ;;=368.2^^55^620^24
 ;;^UTILITY(U,$J,358.3,11396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11396,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,11396,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,11396,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,11397,0)
 ;;=695.3^^55^620^2
 ;;^UTILITY(U,$J,358.3,11397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11397,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,11397,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,11397,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,11398,0)
 ;;=250.00^^55^620^22
 ;;^UTILITY(U,$J,358.3,11398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11398,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,11398,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,11398,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,11399,0)
 ;;=346.90^^55^620^41
 ;;^UTILITY(U,$J,358.3,11399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11399,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,11399,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,11399,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,11400,0)
 ;;=376.30^^55^620^30
 ;;^UTILITY(U,$J,358.3,11400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11400,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,11400,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,11400,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,11401,0)
 ;;=368.8^^55^620^7
 ;;^UTILITY(U,$J,358.3,11401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11401,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,11401,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,11401,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,11402,0)
 ;;=362.34^^55^620^5
 ;;^UTILITY(U,$J,358.3,11402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11402,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,11402,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,11402,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,11403,0)
 ;;=368.13^^55^620^88
 ;;^UTILITY(U,$J,358.3,11403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11403,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,11403,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,11403,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,11404,0)
 ;;=368.40^^55^620^113
 ;;^UTILITY(U,$J,358.3,11404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11404,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,11404,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,11404,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,11405,0)
 ;;=369.4^^55^620^58
 ;;^UTILITY(U,$J,358.3,11405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11405,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,11405,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,11405,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,11406,0)
 ;;=250.01^^55^620^21
 ;;^UTILITY(U,$J,358.3,11406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11406,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,11406,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,11406,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,11407,0)
 ;;=V08.^^55^620^40
 ;;^UTILITY(U,$J,358.3,11407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11407,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,11407,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,11407,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,11408,0)
 ;;=921.0^^55^620^16
 ;;^UTILITY(U,$J,358.3,11408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11408,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,11408,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,11408,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,11409,0)
 ;;=379.91^^55^620^87
 ;;^UTILITY(U,$J,358.3,11409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11409,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,11409,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,11409,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,11410,0)
 ;;=V58.69^^55^620^44
 ;;^UTILITY(U,$J,358.3,11410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11410,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,11410,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,11410,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,11411,0)
 ;;=871.4^^55^620^54
 ;;^UTILITY(U,$J,358.3,11411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11411,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,11411,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,11411,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,11412,0)
 ;;=242.90^^55^620^108
 ;;^UTILITY(U,$J,358.3,11412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11412,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,11412,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,11412,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,11413,0)
 ;;=135.^^55^620^101
 ;;^UTILITY(U,$J,358.3,11413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11413,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,11413,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,11413,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,11414,0)
 ;;=446.5^^55^620^107
 ;;^UTILITY(U,$J,358.3,11414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11414,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,11414,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,11414,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,11415,0)
 ;;=401.9^^55^620^49
 ;;^UTILITY(U,$J,358.3,11415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11415,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,11415,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,11415,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,11416,0)
 ;;=V72.0^^55^620^32
 ;;^UTILITY(U,$J,358.3,11416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11416,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,11416,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,11416,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,11417,0)
 ;;=V41.0^^55^620^91
 ;;^UTILITY(U,$J,358.3,11417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11417,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,11417,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,11417,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,11418,0)
 ;;=998.59^^55^620^89
 ;;^UTILITY(U,$J,358.3,11418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11418,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,11418,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,11418,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,11419,0)
 ;;=042.^^55^620^1
 ;;^UTILITY(U,$J,358.3,11419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11419,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,11419,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,11419,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,11420,0)
 ;;=053.29^^55^620^43
 ;;^UTILITY(U,$J,358.3,11420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11420,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,11420,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,11420,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,11421,0)
 ;;=054.40^^55^620^42
 ;;^UTILITY(U,$J,358.3,11421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11421,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,11421,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,11421,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,11422,0)
 ;;=190.1^^55^620^83
 ;;^UTILITY(U,$J,358.3,11422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11422,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,11422,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,11422,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,11423,0)
 ;;=190.2^^55^620^50
 ;;^UTILITY(U,$J,358.3,11423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11423,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,11423,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,11423,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,11424,0)
 ;;=190.7^^55^620^52
 ;;^UTILITY(U,$J,358.3,11424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11424,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,11424,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,11424,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,11425,0)
 ;;=202.81^^55^620^61
 ;;^UTILITY(U,$J,358.3,11425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11425,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,11425,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,11425,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,11426,0)
 ;;=215.9^^55^620^85
 ;;^UTILITY(U,$J,358.3,11426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11426,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,11426,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,11426,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,11427,0)
 ;;=224.2^^55^620^51
 ;;^UTILITY(U,$J,358.3,11427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11427,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,11427,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,11427,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,11428,0)
 ;;=224.5^^55^620^96
